We found that sorted tumor-infiltrating CD33high cells expressed high levels of CD33 gene, while lacked gene expression of CD3E, CD8A and NCAM1 (gene for CD56), compared to CD8+ T cells (Fig. 2a). This evidence concerns the gene CD8A and neoplasm.